Rational Design of Highly Potent and Slow-Binding Cytochrome bc1 Inhibitor as Fungicide by Computational Substitution Optimization
暂无分享,去创建一个
Ge-Fei Hao | Guang-Fu Yang | Wei Huang | Hui Li | Sheng-Gang Yang | E. Berry | Li-shar Huang | Wei Huang | Hui Li | Guangfu Yang | Jia-Wei Wu | Edward A. Berry | Yan-Qing Shen | Li-Shar Huang | Le Wang | Yan-Qing Shen | Wen-Long Tu | Sheng-Gang Yang | Le Wang | W. Tu | Ge-Fei Hao | Jia-Wei Wu | Li-shar Huang
[1] John Delaney,et al. Modern agrochemical research: a missed opportunity for drug discovery? , 2006, Drug discovery today.
[2] Nathan Brown,et al. Fragment-based hit identification: thinking in 3D. , 2013, Drug discovery today.
[3] V. Barton,et al. Inhibiting Plasmodium cytochrome bc1: a complex issue. , 2010, Current opinion in chemical biology.
[4] Dana Goodman. Thinking in 3D , 2006 .
[5] Robert V. Swift,et al. Rational Prediction with Molecular Dynamics for Hit Identification , 2012, Current topics in medicinal chemistry.
[6] Zhengming Li,et al. Synthesis and biological activity of some novel trifluoromethyl-substituted 1,2,4-triazole and bis(1,2,4-triazole) Mannich bases containing piperazine rings. , 2010, Journal of agricultural and food chemistry.
[7] A. Hopkins,et al. Ligand efficiency: a useful metric for lead selection. , 2004, Drug discovery today.
[8] M. Shaw,et al. Sensitivity distributions and cross-resistance patterns of Mycosphaerella graminicola to fluquinconazole, prochloraz and azoxystrobin over a period of 9 years , 2005 .
[9] Jayaraman Chandrasekhar,et al. Strategies and tactics for optimizing the Hit-to-Lead process and beyond--a computational chemistry perspective. , 2008, Drug discovery today.
[10] Vincent B. Chen,et al. Correspondence e-mail: , 2000 .
[11] A. Hudson,et al. Atovaquone - a novel broad-spectrum anti-infective drug. , 1993, Parasitology today.
[12] A. Caflisch,et al. Molecular dynamics in drug design. , 2015, European journal of medicinal chemistry.
[13] Steven E. Wheeler,et al. Substituent effects in the benzene dimer are due to direct interactions of the substituents with the unsubstituted benzene. , 2008, Journal of the American Chemical Society.
[14] Andrew Plant,et al. Current Challenges and Trends in the Discovery of Agrochemicals , 2013, Science.
[15] C. Zhan,et al. Subnanomolar inhibitor of cytochrome bc1 complex designed by optimizing interaction with conformationally flexible residues. , 2010, Journal of the American Chemical Society.
[16] Rommie E. Amaro,et al. AutoGrow: A Novel Algorithm for Protein Inhibitor Design , 2009, Chemical biology & drug design.
[17] Michael Lanzer,et al. Drug‐resistant malaria: Molecular mechanisms and implications for public health , 2011, FEBS letters.
[18] B. Meunier,et al. Modeling the Qo site of crop pathogens in Saccharomyces cerevisiae cytochrome b. , 2004, European journal of biochemistry.
[19] M. A. Spies,et al. In silico Optimization of a Fragment‐Based Hit Yields Biologically Active, High‐Efficiency Inhibitors for Glutamate Racemase , 2013, ChemMedChem.
[20] Ge-Fei Hao,et al. Computational discovery of picomolar Q(o) site inhibitors of cytochrome bc1 complex. , 2012, Journal of the American Chemical Society.
[21] J. Topliss,et al. Chance factors in studies of quantitative structure-activity relationships. , 1979, Journal of medicinal chemistry.
[22] David M Kramer,et al. A semiquinone intermediate generated at the Qo site of the cytochrome bc1 complex: Importance for the Q-cycle and superoxide production , 2007, Proceedings of the National Academy of Sciences.
[23] J. Todd,et al. A complex issue. , 1995, Trends in Genetics.
[24] Guangfu Yang,et al. A Comparative Study on the Constitutive Properties of Marketed Pesticides , 2011, Molecular informatics.
[25] D Horvath,et al. From hit to lead. Analyzing structure-profile relationships. , 2001, Journal of medicinal chemistry.
[26] Alexander Hillisch,et al. Improving the hit-to-lead process: data-driven assessment of drug-like and lead-like screening hits. , 2006, Drug discovery today.
[27] T. Taylor,et al. A Longitudinal Trial Comparing Chloroquine as Monotherapy or in Combination with Artesunate, Azithromycin or Atovaquone-Proguanil to Treat Malaria , 2012, PloS one.
[28] L. Yu,et al. Quantitative resolution of succinate-cytochrome c reductase into succinate-ubiquinone and ubiquinol-cytochrome c reductases. , 1982, The Journal of biological chemistry.
[29] Wei-Chun Kao,et al. Structural analysis of atovaquone-inhibited cytochrome bc1 complex reveals the molecular basis of antimalarial drug action , 2014, Nature Communications.
[30] Michael F. Rafferty. Hit to lead , 2013 .
[31] U. Gisi,et al. The Challenges of Chemical Control of Plant Diseases , 2010 .
[32] György M Keseru,et al. Hit discovery and hit-to-lead approaches. , 2006, Drug discovery today.
[33] Aiying Guan,et al. Application of the intermediate derivatization approach in agrochemical discovery. , 2014, Chemical reviews.